Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FM71: MED3000 Gel vs Tadalafil for Erectile Dysfunction
NCT04984993Phase 3Completed
- Sponsor
- Futura Medical plc
- Start
- Sep 2021
- Primary completion
- Jul 2022
- Countries
- 4
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Futura Medical plc. Primary endpoint: Change From Baseline in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF) Questionnaire at 24 weeks. Started Sep 2021; status: completed.
Beyond the preview
Go deeper on NCT04984993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984993.